Berman D S, Kiat H, Van Train K, Garcia E, Friedman J, Maddahi J
Department of Nuclear Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Semin Nucl Med. 1991 Jul;21(3):190-212. doi: 10.1016/s0001-2998(05)80040-6.
Extensive work has already been performed with regard to both planar and single photon emission computed (SPECT) technetium 99m sestamibi studies. Before widespread application of optimized acquisition and processing methods, clinical results between 99mTc sestamibi and thallium 201 were remarkably similar. It is anticipated that as techniques for 99mTc sestamibi planar and SPECT imaging become optimized, improvements in sensitivity and specificity for detection of coronary artery disease, over those observed with 201TI, might be forthcoming. This expectation is based on the improved image quality inherent in the use of the 99mTc agent with its higher count rate and higher energy. This improvement in image quality may be a principal reason for laboratories to switch from 201TI to 99mTc sestamibi imaging. It is anticipated that, with improved imaging characteristics, it will be easier for the average community hospital to obtain higher quality planar or SPECT imaging using 99mTc sestamibi rather than 201TI. In addition to improved image quality, the characteristics of 99mTc sestamibi allow gated planar or SPECT perfusion images to be obtained. It has been suggested that stress-gated SPECT sestamibi studies may provide all the information contained in a stress-rest nongated 99mTc sestamibi study, thereby potentially increasing patient throughput, a major concern with SPECT. Throughput can also be increased by using dual-isotope approaches with rest 201TI and stress technetium sestamibi acquisitions, employing either separate or simultaneous imaging with which the entire study can be accomplished in less than 2 hours. With simultaneous dual-isotope acquisition, camera time can be reduced by 50%. Finally, 99mTc sestamibi offers the advantage of the ability to perform first-pass exercise ventricular function and SPECT myocardial perfusion studies with a single injection of tracer. Regarding the assessment of myocardial viability, results to date suggest a very high degree of concordance between 201TI and 99mTc sestamibi studies using either planar or SPECT acquisition techniques. Correlative rest studies with both tracers will be of particular interest, as will preoperative and postoperative and position emission tomography correlation studies.
关于平面和单光子发射计算机断层扫描(SPECT)锝99m甲氧基异丁基异腈研究,已经开展了大量工作。在广泛应用优化的采集和处理方法之前,锝99m甲氧基异丁基异腈和铊201的临床结果非常相似。预计随着锝99m甲氧基异丁基异腈平面和SPECT成像技术的优化,与铊201相比,在检测冠状动脉疾病方面的敏感性和特异性可能会提高。这一预期基于使用锝99m制剂时固有的图像质量改善,其具有更高的计数率和更高的能量。图像质量的这种改善可能是实验室从铊201转向锝99m甲氧基异丁基异腈成像的主要原因。预计随着成像特性的改善,普通社区医院使用锝99m甲氧基异丁基异腈而不是铊201更容易获得更高质量的平面或SPECT成像。除了图像质量提高外,锝99m甲氧基异丁基异腈的特性还允许获得门控平面或SPECT灌注图像。有人提出,负荷门控SPECT甲氧基异丁基异腈研究可能提供负荷-静息非门控锝99m甲氧基异丁基异腈研究中包含的所有信息,从而有可能提高患者通量,这是SPECT的一个主要关注点。通过使用静息铊201和负荷锝甲氧基异丁基异腈采集的双同位素方法,采用单独或同时成像,整个研究可以在不到2小时内完成,也可以提高通量。采用同时双同位素采集时,相机时间可减少50%。最后,锝99m甲氧基异丁基异腈的优点是能够通过单次注射示踪剂进行首次通过运动心室功能和SPECT心肌灌注研究。关于心肌存活性的评估,迄今为止的结果表明,使用平面或SPECT采集技术,铊201和锝99m甲氧基异丁基异腈研究之间具有高度一致性。两种示踪剂的相关静息研究将特别有趣,术前和术后以及正电子发射断层扫描相关研究也将如此。